Cell and Gene Therapy in Lung Transplantation: From Experimental Promise towards Clinical Translation
Open Access
- 28 October 2026
- journal article
- Published by Elsevier in The Journal of Heart and Lung Transplantation
Abstract
No abstract availableFunding Information
- European Commission
- Fonds Wetenschappelijk Onderzoek
- Universitaire Ziekenhuizen Leuven, KU Leuven
This publication has 69 references indexed in Scilit:
- Adeno-associated virus–mediated transduction of PD-L1 in a rodent lung transplant modelAmerican Journal of Transplantation, 2025
- MiR‐146a engineered extracellular vesicles derived from mesenchymal stromal cells more potently attenuate ischaemia–reperfusion injury in lung transplantationClinical and Translational Medicine, 2025
- OPTN/SRTR 2023 Annual Data Report: LungAmerican Journal of Transplantation, 2025
- Gene therapy clinical trials worldwide to 2023—an updateThe Journal of Gene Medicine, 2024
- Minimal information for studies of extracellular vesicles (MISEV2023): From basic to advanced approachesJournal of Extracellular Vesicles, 2024
- Treatment to cure: Advancing AAV gene therapy manufactureDrug Discovery Today, 2023
- Engineered virus-like particles for efficient in vivo delivery of therapeutic proteinsCell, 2022
- Mesenchymal Stromal Cell Therapy for Chronic Lung Allograft Dysfunction: Results of a First-in-Man StudyStem Cells Translational Medicine, 2017
- Novel autologous T-cell therapy for drug-resistant cytomegalovirus disease after lung transplantationThe Journal of Heart and Lung Transplantation, 2016
- Intratracheal administration of p38α short-hairpin RNA plasmid ameliorates lung ischemia-reperfusion injury in ratsThe Journal of Heart and Lung Transplantation, 2012